Annovis Bio, Inc. (ANVS) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANVS Hot Sheet
Join SI Premium – FREE
Annovis Bio, Inc. (NYSE: ANVS) reported Q2 EPS of ($0.32), $0.08 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- No Visa Required: SMX Passport Moves Physical Assets into the Digital Economy
- New FarmBot Tech Research Finds US Precision Agriculture Use Fell From 27% to 22% as Farm Bankruptcies Rose 46%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
